Join
Live feed
·
INSIDERFilingvia Quantisnow
Vor Biopharma Inc. logo

CHIEF SCIENTIFIC OFFICER Chakraborty Tirtha covered exercise/tax liability with 1,163 shares and was granted 52,500 shares, increasing direct ownership by 30% to 221,272 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VOR· Vor Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VOR (Vor Biopharma Inc.) and more on Quantisnow.